• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Cancer Types
  • Radiotherapy
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Immune Oncology
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Jan / 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Dec    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

France Expands Reimbursed Compassionate Access for Botensilimab/Balstilimab to Ovarian Cancer and Soft-Tissue Sarcomas

Botensilimab/Balstilimab

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

100 Most Influential CEOs

TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC

TWINPEAK study

Merck Could Strike 30 Billion Deal for Revolution Medicines

merck

The Onco-Bronchology International Conference (Onco-Broncho 2026)

Onco-Bronchology

10 Oncology Specialists Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

Syria And Hematogenix Sign Agreement To Establish Advanced Cancer Center In Damascus

Syria And Hematogenix Sign Agreement - OncoDaily

Jeffrey Bluestone: Kick-Ass Science, Collaborate Like Hell, Make a Difference

Jeffrey Bluestone

OncoCalendar

12 events found.

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
Today
  • November 2025

  • Thu 20
    The SIOG 2025 Annual Conference
    Nov 20, 2025 • 8:00 AM - Nov 22, 2025 • 5:00 PM

    The SIOG 2025 Annual Conference

    International Convention Centre of Ghent Citadelpark 1, Ghent

    The SIOG 2025 Annual Conference will take place in person from 20 to 22 November 2025 at the International Convention Centre of Ghent (Gent ICC) in Belgium. This in-person event will […]

  • Fri 21
    ESO
    Nov 21, 2025 - Nov 23, 2025

    The ESO Refresher Course on Breast Cancer

    The ESO Refresher Course on Breast Cancer is a training program designed for medical, surgical, and radiation oncologists, pathologists, and radiologists involved in breast cancer management. Scheduled for November 21-23, […]

  • Fri 21
    ESMO Advanced Course
    Nov 21, 2025 - Nov 22, 2025

    ESMO Advanced Course on ADC Development, Therapeutic Applications and Research in Breast Cancer 2025: Barcelona

    The ESMO Advanced Course on ADC Development, Therapeutic Applications and Research in Breast Cancer 2025 will be held on 21–22 November 2025 in Barcelona, Spain. This course, chaired by Prof. Javier Cortés and Prof. Nadia Harbeck, provides an in-depth exploration of antibody-drug conjugates (ADCs), covering drug development, mechanisms of action, integration into clinical practice, and […]

  • Fri 21
    ESMO Advanced Course
    Nov 21, 2025 - Nov 22, 2025

    ESMO Advanced Course on Cholangiocarcinoma 2025: Barcelona

    Hotel Barcelona Center Carrer de Balmes, 103‑105, Eixample, Barcelona, Spain

    The ESMO Advanced Course on Cholangiocarcinoma 2025 will be held on 21–22 November 2025 at the Hotel Barcelona Center in Barcelona, Spain. This course provides a comprehensive update on the diagnosis, molecular profiling, and management of cholangiocarcinoma, covering surgery, locoregional therapies, immunotherapy, targeted treatments, and both adjuvant and palliative strategies. Accredited with 11 ESMO-MORA points, […]

  • Fri 21
    IASLC 2025 Hot Topic
    Nov 21, 2025 - Nov 23, 2025

    IASLC 2025 Hot Topic in Basic and Translational Science: Unraveling Precancer and Early-Stage Lung Cancer

    Hilton Tokyo 6-6-2 Nishi-Shinjuku, Shinjuku-ku, Tokyo, Shinjuku, Japan

    The IASLC 2025 Hot Topic in Basic and Translational Science: Unraveling Precancer and Early-Stage Lung Cancer meeting is a three-day event in Tokyo, Japan, dedicated to advancing the understanding and […]

  • Fri 21
    ESMO 2025
    Nov 21, 2025 • 8:30 AM - 6:35 PM

    Best of ESMO 2025 Vilnius

    Radisson BLU Hotel Lietuva Konstitucijos pr. 20, Vilnius, Lithuania

    The Hybrid Conference “Best of ESMO 2025,” an ESMO Licensed Event, will take place on 21 November at Radisson BLU Hotel Lietuva in Vilnius, Lithuania. Organized by the Lithuanian Society […]

  • Fri 21
    ECHoS
    Nov 21, 2025 • 9:00 AM - 1:00 PM

    ECHoS Town Hall Meeting

    Radisson Collection Hotel, Grand Place Brussels Rue du Fossé aux Loups 47, Bruxelles (Brussels), Bruxelles, Belgium

    The ECHoS Town Hall Meeting is a landmark event centered on the implementation of the Horizon Europe ECHoS project, which is dedicated to establishing national hubs across EU countries to […]

  • Sat 22
    ESMO Gulf
    Nov 22, 2025 - Nov 23, 2025

    Best of ESMO Gulf 2025

    Grand Plaza Mövenpick Media City Al Falak Street, Opposite Innovation Hub, Dubai Media City, Dubai, United Arab Emirates

    The Best of ESMO Gulf 2025, organized by the Emirates Oncology Society, will take place on 22–23 November 2025 at the Grand Plaza Mövenpick Media City, Dubai. This hybrid event […]

  • Mon 24
    AGITG
    Nov 24, 2025 - Nov 27, 2025

    AGITG 27th Annual Scientific Meeting

    Adelaide Convention Centre North Terrace, Adelaide, South Australia, Australia

    The 27th Annual Scientific Meeting of the Australasian Gastrointestinal Trials Group (AGITG) is a four-day conference focused on advancing GI cancer research through partnership. Held in Tarntanya/Adelaide from November 24–27, […]

  • Mon 24
    London Global Cancer Week, Equity
    Nov 24, 2025 - Nov 28, 2025

    London Global Cancer Week (LGCW) 2025

    The London Global Cancer Week (LGCW) 2025 is a week-long series of multi-disciplinary, collaborative events scheduled from November 24 to 28, 2025, in London, UK. LGCW acts as a catalyst […]

  • Mon 24
    Common Sense Oncology, LGCW 2025
    Nov 24, 2025 • 6:00 PM - 7:00 PM

    LGCW 2025: Common Sense Oncology – Outcomes that Matter

    The LGCW 2025: Common Sense Oncology - Outcomes that Matter webinar is a virtual meeting scheduled for Monday, November 24th, 2025, from 6:00 PM to 7:00 PM GMT. The event […]

  • Tue 25
    Early Childhood Cancer Diagnosis
    Nov 25, 2025

    Breaking Barriers: Strengthening Early Childhood Cancer Diagnosis in Ghana and South Africa

    The webinar, "Breaking Barriers: Strengthening Early Childhood Cancer Diagnosis in Ghana and South Africa," is a vital session hosted by World Child Cancer and CHOC Childhood Cancer Foundation SA as part of London Global Cancer Week. Scheduled for November 25, 2025, at 12:00 PM GMT, the event will highlight the progress and challenges in early […]

  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research ESMO Headlines MD Anderson Cancer Center immunotherapy NSCLC cancer awareness cancer treatment Research ASCO24 colorectal cancer Childhood Cancer prostate cancer AACR clinical trials FDA UICC Dana-Farber Cancer Institute European Cancer Organisation American Cancer Society SIOP NCI chemotherapy Myeloma National Cancer Institute Robert Orlowski American Society of Clinical Oncology Vivek Subbiah healthcare Myeloma Paper of the Day Paolo Tarantino Pancreatic Cancer AI IASLC ASCO25 radiation oncology WHO multiple myeloma cervical cancer Memorial Sloan Kettering Cancer Center Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}